
NYSE:IBM
This summary was created by AI, based on 26 opinions in the last 12 months.
IBM's recent performance has been mixed, highlighted by significant stock fluctuations and earnings surprises. While some analysts noted a severe drop in share price following earnings, with concerns about execution slips and high valuations, others pointed to the company's strengths, including its robust AI and quantum computing initiatives. The stock's current price levels seem volatile, with predictions of further declines unless stabilization occurs around key support levels. Despite the potential for growth driven by AI and software services, and recent strong earnings reports, there remain skeptics who believe IBM's valuation may be overstated given current market dynamics. Overall, the outlook varies widely among experts, reflecting both the challenges and opportunities the company faces in a competitive landscape.
Boring, but now things are coming together. Left a lot of baggage behind with the spinoff, but kept Watson, a leader in AI applications in healthcare. Lot of horses that they haven't yet raced. 12-month price target of $257. Yield is 3%.
(Analysts’ price target is $191.36)Transitioning to more services. Has done all right. Trades at 16x. Has to prove it can grow double-digit earnings on a sustainable basis before it gets recognition from market, and this is harder for such a large company. Higher rates are impacting customers' budgets, seeing softness.
Decent. She prefers names with better growth profiles. Spun off mainframe business, which improves growth profile. Now just consulting. Stock's done well, now getting into cybersecurity and AI.